Jason D. Fontenot is SVP, Chief Scientific Officer of Sangamo Therapeutics Inc.
Person profile
Roles
Sangamo Therapeutics
SVP, Chief Scientific Officer
Address
Brisbane, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
SANGAMO THERAPEUTICS, INC
28 Nov 23
4
SANGAMO THERAPEUTICS, INC
29 Aug 23
4
SANGAMO THERAPEUTICS, INC
30 May 23
4
SANGAMO THERAPEUTICS, INC
6 Mar 23
4
SANGAMO THERAPEUTICS, INC
27 Apr 22
4
SANGAMO THERAPEUTICS, INC
1 Mar 22
4
SANGAMO THERAPEUTICS, INC
27 Apr 21
3
SANGAMO THERAPEUTICS, INC
19 Mar 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
25 Nov 23 | SGMO Sangamo Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 0.3821 | 1,030 | 393.56 | 136,270 |
25 Aug 23 | SGMO Sangamo Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 0.77 | 1,029 | 792.33 | 137,300 |
25 May 23 | SGMO Sangamo Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 1.33 | 1,029 | 1.37 k | 138,329 |
25 Feb 23 | SGMO Sangamo Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 2.66 | 6,559 | 17.45 k | 139,358 |
24 Feb 23 | SGMO Sangamo Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 42,750 | 0.00 | 145,917 |
24 Feb 23 | SGMO Sangamo Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.66 | 199,500 | 530.67 k | 199,500 |